Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDFR0812 in premature ejaculation
NCT02571101Phase 2Unknown
- Sponsor
- CTC Bio
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clomipramine and ASP-001 in premature ejaculation (PE) (3 arms), sponsored by CTC Bio. Primary endpoint: Fold change of Intravaginal Ejaculatory Latency Time at 8 weeks. Status: unknown.
02
Drugs
clomipramineASP-001
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT02571101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571101.